| P50 | author | Kirsten M M Beyer | Q82047310 |
| | Liliana E. Pezzin | Q88938141 |
| | Joan M Neuner | Q90511610 |
| | Nicole Fergestrom | Q90664202 |
| P2093 | author name string | Purushottam W Laud | |
| | Kathryn E Flynn | |
| | Ann B Nattinger | |
| P2860 | cites work | Adherence and persistence associated with an appointment-based medication synchronization program | Q44850064 |
| | Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry | Q45385473 |
| | Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I-III breast cancer: A systematic review and meta-analysis. | Q50907251 |
| | Adherence influencing factors in patients taking oral anticancer agents: a systematic review. | Q51840555 |
| | Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer | Q63365966 |
| | The implications of therapeutic complexity on adherence to cardiovascular medications | Q84069362 |
| | Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy | Q87732217 |
| | The impact of a retail prescription synchronization program on medication adherence | Q88654528 |
| | Factors Influencing Prescription Drug Synchronization: The Complex Role of Number of Medications | Q92332990 |
| | Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer | Q24632347 |
| | Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy | Q33756382 |
| | Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D. | Q33969482 |
| | Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy | Q34020925 |
| | The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer | Q34736154 |
| | Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations | Q35060868 |
| | Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer | Q35925132 |
| | Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer | Q36064866 |
| | The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees | Q36087210 |
| | Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer | Q36292773 |
| | Adherence to tamoxifen over the five-year course | Q36422926 |
| | Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques | Q36488716 |
| | Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review | Q36713559 |
| | Adherence to endocrine therapy for breast cancer | Q36754119 |
| | Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer | Q36788354 |
| | A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients | Q36832684 |
| | Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases | Q37055744 |
| | Adjuvant hormonal therapy use among insured, low-income women with breast cancer | Q37280714 |
| | Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study | Q37627696 |
| | Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review | Q37669380 |
| | Adherence enhancing interventions for oral anticancer agents: a systematic review | Q38126149 |
| | American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. | Q38661869 |
| | Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review | Q38822474 |
| | Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer | Q40136245 |
| | Impact of Appointment-Based Medication Synchronization on Existing Users of Chronic Medications | Q40670068 |
| | Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer | Q44315385 |
| P433 | issue | 22 | |
| P921 | main subject | pharmacy | Q614304 |
| P304 | page(s) | 3960-3965 | |
| P577 | publication date | 2019-08-02 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence | |
| P478 | volume | 125 | |